Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/16/21
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020GlobeNewsWire • 03/15/21
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021GlobeNewsWire • 03/08/21
Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare ConferenceGlobeNewsWire • 02/26/21
Do Options Traders Know Something About Amphastar (AMPH) Stock We Don't?Zacks Investment Research • 12/11/20
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
Amphastar Pharmaceuticals' (AMPH) Management on Q3 2020 Results - Quick Version Earnings Call TranscriptSeeking Alpha • 11/06/20
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020GlobeNewsWire • 11/06/20
Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate InjectionGlobeNewsWire • 10/06/20
Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare ConferenceGlobeNewsWire • 09/03/20
Amphastar Pharmaceuticals' (AMPH) Management on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/08/20
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020GlobeNewsWire • 07/30/20
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare ConferenceGlobeNewsWire • 06/19/20
Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation ConferenceGlobeNewsWire • 06/12/20